Fenbufen: Difference between revisions
m Protected "Fenbufen": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{ | {{Drugbox | ||
| IUPAC_name = | | verifiedrevid = 443753907 | ||
| image = Fenbufen. | | IUPAC_name = 4-(4-Biphenylyl)-4-oxobutanoic acid<br>or<br>4-Oxo-4-(4-phenylphenyl)butanoic acid | ||
| | | image = Fenbufen.png | ||
| image2 = Fenbufen-from-xtal-1988-3D-balls.png | |||
| | <!--Clinical data--> | ||
| | | tradename = | ||
| Drugs.com = {{drugs.com|international|fenbufen}} | |||
| | | pregnancy_category = | ||
| legal_status = POM | |||
| pregnancy_category = | |||
| legal_status = | |||
| routes_of_administration = Oral | | routes_of_administration = Oral | ||
<!--Pharmacokinetic data--> | |||
| bioavailability = | |||
| protein_bound = | |||
| metabolism = | |||
| elimination_half-life = | |||
| excretion = | |||
<!--Identifiers--> | |||
| CAS_number = 36330-85-5 | |||
| ATC_prefix = M01 | |||
| ATC_suffix = AE05 | |||
| ATC_supplemental = | |||
| PubChem = 3335 | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| DrugBank = DB08981 | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | |||
| ChemSpiderID = 3218 | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = 9815R1WR9B | |||
| KEGG_Ref = {{keggcite|correct|kegg}} | |||
| KEGG = D01344 | |||
| ChEBI_Ref = {{ebicite|correct|EBI}} | |||
| ChEBI = 31599 | |||
| ChEMBL_Ref = {{ebicite|correct|EBI}} | |||
| ChEMBL = 277522 | |||
<!--Chemical data--> | |||
| C=16 | H=14 | O=3 | |||
| molecular_weight = 254.2854 | |||
| smiles = O=C(O)CCC(=O)c2ccc(c1ccccc1)cc2 | |||
| InChI = 1/C16H14O3/c17-15(10-11-16(18)19)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h1-9H,10-11H2,(H,18,19) | |||
| InChIKey = ZPAKPRAICRBAOD-UHFFFAOYAO | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChI = 1S/C16H14O3/c17-15(10-11-16(18)19)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h1-9H,10-11H2,(H,18,19) | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChIKey = ZPAKPRAICRBAOD-UHFFFAOYSA-N | |||
}} | }} | ||
'''Fenbufen''' is a [[non-steroidal anti-inflammatory drug]] used primarily to treat inflammation in [[osteoarthritis]], [[ankylosing spondylitis]], and [[tendinitis]]. It can also be used to relieve backaches, sprains, and fractures. Fenbufen is available as a capsule or tablet sold with the brand names '''Cepal''', '''Cinopal''', '''Cybufen''', '''Lederfen''', and '''Reugast'''. Fenbufen acts by preventing [[cyclooxygenase]] from producing | |||
{{ | __NOTOC__ | ||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Fenbufen''' is a [[non-steroidal anti-inflammatory drug]] used primarily to treat inflammation in [[osteoarthritis]], [[ankylosing spondylitis]], and [[tendinitis]]. It can also be used to relieve backaches, sprains, and fractures. Fenbufen is available as a capsule or tablet sold with the brand names '''Cepal''', '''Cinopal''', '''Cybufen''', '''Lederfen''', and '''Reugast'''. Fenbufen acts by preventing [[cyclooxygenase]] from producing [[prostaglandin]]s which can cause inflammation. | |||
==References== | |||
{{Reflist|2}} | |||
{{Anti-inflammatory and antirheumatic products}} | {{Anti-inflammatory and antirheumatic products}} | ||
[[Category:Non-steroidal anti-inflammatory drugs]] | [[Category:Non-steroidal anti-inflammatory drugs]] | ||
[[Category: | [[Category:Drug]] | ||
Latest revision as of 16:27, 11 April 2015
 | |
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C16H14O3 |
| Molar mass | 254.2854 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
|
WikiDoc Resources for Fenbufen |
|
Articles |
|---|
|
Most recent articles on Fenbufen |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Fenbufen at Clinical Trials.gov Clinical Trials on Fenbufen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Fenbufen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Fenbufen Risk calculators and risk factors for Fenbufen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Fenbufen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Fenbufen is a non-steroidal anti-inflammatory drug used primarily to treat inflammation in osteoarthritis, ankylosing spondylitis, and tendinitis. It can also be used to relieve backaches, sprains, and fractures. Fenbufen is available as a capsule or tablet sold with the brand names Cepal, Cinopal, Cybufen, Lederfen, and Reugast. Fenbufen acts by preventing cyclooxygenase from producing prostaglandins which can cause inflammation.